Nothing short of miraculous....When TLT said" Comparing the 90 days and the 180 days assesment data, demonstrate that once a patients has obtained CR(Complete Response) or PR the duration of the response remain fairly durable".
Optimized Patients...
What the above mean is as we speak the potential CR(Complete Response) % is around 94.4 % at 90 days for the optimized patients. Knowing that the the CR % remain fairly durable, just to be on the safe side... TLT optimized patients could easily acheive 75 to 85% CR(Complete Response) at 180,260 ...days (that would be huge not to say humongous).
The big question is... Why is it that the optimized patients remain cancer free after 90,180,260...days????
To find a possible answer we have to go back to 2014 (TLT was doing preclinical studies).
PressRelease June 24,2014
PressRelease Nov 12, 2014
TLT said " TLT PDC technology demonstrates an ability to effectively destroy both Normoxix and Hypoxix cancer cells, this suggest an application of this technology to virtually all cancers, including later stage cancers(Bladder BCG resistant patients), that present with Hypoxix area and cores that can prove resistant to most form of treatment, also the ability of TLT PDC to destroy the original cancer and also program the body's immune system to prevent its recurence, after only one single treatment, is nothing short of miraculous".
The above could be the reason for the durable response.
TLT treatment doesn't just cure the cancer...it can also program the immune system of the patient to fight recurrence on its own.
No wonder FDA gave fast-track designation to TLT.
How much money a big pharma Partner will be willing to pay, to be TLT partner in commercialization of this miraculous cancer treatment that could work virtually on all cancers.
All bets are open.